Apeloa Pharmaceutical Co.,Ltd (000739)

Overview

Apeloa Pharmaceutical Co., Ltd, established in 1989 and headquartered in Dongyang, China, stands as a pivotal player in the pharmaceutical industry, both domestically and on the international stage. The company is dedicated to providing a comprehensive range of raw materials and intermediates that cater to various pharmaceutical factories. Emphasizing innovation and quality, Apeloa Pharmaceutical has developed an expansive portfolio of preparation products. These products target a broad spectrum of therapeutic areas including cardio-cerebrovascular diseases, anti-infection, anti-tumor, anti-viral treatments, and a line of specialty drugs. The company distributes its top-end pharmaceutical offerings under well-recognized brand names such as Tianliwei, Beshin, Yosemade, Jutai, among others. Through its tireless efforts in R&D and an unwavering commitment to quality, Apeloa Pharmaceutical continues to fortify its position in the global pharmaceutical market while contributing significantly to healthcare and patient well-being.

Products and Services

• Cardio-Cerebrovascular Products: Apeloa Pharmaceutical offers a range of products specifically designed to treat cardio-cerebrovascular diseases. These medications aim to improve heart function, reduce the risk of stroke, and enhance overall cardiovascular health.
• Anti-Infection Products: Recognizing the critical impact of bacterial, viral, and fungal infections, the company has developed a robust lineup of anti-infection drugs. These products are formulated to combat various infectious diseases, ensuring effective treatment and recovery for patients.
• Anti-Tumor Products: With a keen focus on oncology, Apeloa Pharmaceutical provides a variety of anti-tumor medications. These drugs are developed through cutting-edge research to target different types of cancer, aiming to improve survival rates and quality of life for cancer patients.
• Anti-Viral Products: In response to the growing threat of viral epidemics, the company offers a specialized segment of anti-viral drugs. These products are engineered to treat and prevent various viral infections, contributing to the global effort against viral diseases.
• Special Drugs: Beyond their mainstream product lines, Apeloa Pharmaceutical also develops and markets special drugs designed to meet specific therapeutic needs. This category encompasses a diverse range of treatments for less common conditions and diseases, showcasing the company’s dedication to comprehensive healthcare solutions.